Canada

Health Canada expected to approve Pfizer’s COVID-19 therapeutic today: sources | CBC News

News Today || Canada News |

Health Canada is expected to approve Pfizer’s COVID-19 therapeutic today for use in this country, sources told CBC News and Radio-Canada.

Dr. Supriya Sharma, the health regulator’s chief medical adviser, will speak to the media at 11 a.m. ET. CBCNews.ca will carry her remarks live.

Pfizer’s Paxlovid, which is an antiviral prescribed by a doctor and administered in pill form, is designed to help the body fight off the SARS-CoV-2 virus, reduce symptoms from an infection and shorten the period of illness.

Ads

The product has been hailed as a pandemic “game changer” by some doctors because it could reduce hospitalizations and deaths among COVID-19 patients. An effective pill that’s easy to self-administer at home could relieve some of the pressure on the health-care system and change the trajectory of the pandemic, experts say.

After months-long clinical trials, Pfizer reported in November that Paxlovid reduced the risk of hospitalization or death by an impressive 89 per cent compared to a placebo in non-hospitalized high-risk adults with COVID-19.

Canada has placed an order for an initial quantity of one million treatment courses. Some of that supply will start to arrive after Health Canada’s expected approval.

Latest Canadian News Today & Breaking Headlines – Check More

Today News || News Now || World News || US Headlines || Health || Technology News || Education News

Source

Tags
Show More

Related Articles

Back to top button
Close